Publicaciones en colaboración con investigadores/as de Sahlgrenska University Hospital (4)

2017

  1. Inhibition of T-Cell activation by the CTLA4-Fc abatacept is sufficient to ameliorate proteinuric kidney disease

    American Journal of Physiology - Renal Physiology, Vol. 312, Núm. 4, pp. F748-F759

2008

  1. The CREATE Project: Development of certified reference materials for allergenic products and validation of methods for their quantification

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 63, Núm. 3, pp. 310-326